Shares and Stockholders’ Equity (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
Stockholders' Equity Note [Abstract] |
|
Schedule of Changes in Preferred |
Preferred stock authorized, issued and outstanding (number of shares) was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2024 | | As of December 31, 2023 | | Shares Authorized | | Shares Issued | | Shares Outstanding | | Shares Authorized | | Shares Issued | | Shares Outstanding | 9.250% Fixed Rate Reset Non-Cumulative | | | | | | | | | | | | Preferred Stock, Series C | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | 9.000% Non-Cumulative Preferred Stock, Series D | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | Not designated | 9,960,000 | | | – | | | – | | | 9,960,000 | | | – | | | – | | Total preferred shares | 10,000,000 | | | 40,000 | | | 40,000 | | | 10,000,000 | | | 40,000 | | | 40,000 | |
The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended September 30, | | 2024 | | 2023 | | Dividend | | Aggregate | | Dividend | | Aggregate | Series | Per Share | | Dividend | | Per Share | | Dividend | Series C | $ | 1,156.25 | | | $ | 23 | | | $ | 1,156.25 | | | $ | 23 | | Series D | 562.50 | | | 11 | | | 562.50 | | | 11 | | Total | $ | 1,718.75 | | | $ | 34 | | | $ | 1,718.75 | | | $ | 34 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Nine Months Ended September 30, | | | 2024 | | | 2023 | | | | | | | | | | | | | | | Dividend | | | Aggregate | | | Dividend | | | Aggregate | Series | | Per Share | | | Dividend | | | Per Share | | | Dividend | Series C | | $ | 2,312.50 | | | | $ | 46 | | | | $ | 1,792.19 | | | | $ | 36 | | Series D | | 1,687.50 | | | | 34 | | | | 1,743.75 | | | | 35 | | Total | | $ | 4,000.00 | | | | $ | 80 | | | | $ | 3,535.94 | | | | $ | 71 | |
|
Schedule of Common Stock Outstanding Roll Forward |
The changes in our common stock (number of shares) were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, | | 2024 | | 2023 | | 2024 | | | 2023 | Common Stock | | | | | | | | | Balance as of beginning-of-period | 170,188,487 | | | 169,630,880 | | | 169,666,137 | | | | 169,220,511 | | Stock compensation/issued for benefit plans | 152,980 | | | 27,391 | | | 675,330 | | | | 437,760 | | | | | | | | | | | Balance as of end-of-period | 170,341,467 | | | 169,658,271 | | | 170,341,467 | | | | 169,658,271 | | | | | | | | | | |
|
Reconciliation of the Denominator Calculations of Basic and Diluted Earnings per Share |
The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended September 30, | | | | For the Nine Months Ended September 30, | | 2024 | | 2023 | | | | 2024 | | | 2023 | Net income (loss) available to common stockholders – basic | $ | (562) | | | $ | 819 | | | | | $ | 1,508 | | | | $ | 412 | | Net income (loss) available to common stockholders – diluted | $ | (562) | | | $ | 819 | | | | | $ | 1,511 | | | | $ | 410 | | | | | | | | | | | | | Weighted-average shares, as used in basic calculation | 170,773,438 | | 169,645,881 | | | | 170,482,264 | | | 169,529,509 | Incremental common shares from assumed exercise or | | | | | | | | | | | issuance of stock-based incentive compensation awards | 2,075,432 | | 623,039 | | | | 1,575,034 | | | 507,752 | Average deferred compensation shares | — | | 621,582 | | | | 710,256 | | | 588,183 | Weighted-average shares, as used in diluted calculation (1) | 172,848,870 | | 170,890,502 | | | | 172,767,554 | | | 170,625,444 | | | | | | | | | | | | Net income (loss) per share: | | | | | | | | | | | Basic | $ | (3.29) | | | $ | 4.82 | | | | | $ | 8.85 | | | | $ | 2.43 | | Diluted | (3.29) | | | 4.79 | | | | | 8.75 | | | | 2.40 | |
(1) Due to reporting a net loss for the three months ended September 30, 2024, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.
|
Components and Changes in AOCI |
The following summarizes the components and changes in AOCI (in millions):
| | | | | | | | | | | | | For the Nine Months Ended September 30, | | 2024 | | 2023 | Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain | | | | Other Investments | | | | Balance as of beginning-of-year | $ | (5,188) | | | $ | (8,916) | | | | | | Unrealized holding gains (losses) arising during the period | 1,555 | | | (3,405) | | Change in foreign currency exchange rate adjustment | 124 | | | (21) | | | | | | Change in future contract benefits and policyholder account balances, | | | | net of reinsurance | (382) | | | 27 | | Income tax benefit (expense) | (276) | | | 707 | | Less: | | | | Reclassification adjustment for gains (losses) included in net income (loss) | (163) | | | (1,145) | | | | | | | | | | Income tax benefit (expense) | 34 | | | 240 | | Balance as of end-of-period | $ | (4,038) | | | $ | (10,703) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealized Gain (Loss) on Derivative Instruments | | | | Balance as of beginning-of-year | $ | 375 | | | $ | 388 | | | | | | Unrealized holding gains (losses) arising during the period | 305 | | | 231 | | Change in foreign currency exchange rate adjustment | (121) | | | 30 | | | | | | | | | | Income tax benefit (expense) | (39) | | | (55) | | Less: | | | | Reclassification adjustment for gains (losses) included in net income (loss) | 60 | | | 68 | | | | | | Income tax benefit (expense) | (13) | | | (14) | | Balance as of end-of-period | $ | 473 | | | $ | 540 | | Market Risk Benefit Non-Performance Risk Gain (Loss) | | | | Balance as of beginning-of-year | $ | 1,070 | | | $ | 1,741 | | | | | | Adjustment arising during the period | (367) | | | (944) | | Income tax benefit (expense) | 78 | | | 202 | | Balance as of end-of-period | $ | 781 | | | $ | 999 | | Policyholder Liability Discount Rate Remeasurement Gain (Loss) | | | | Balance as of beginning-of-year | $ | 587 | | | $ | 747 | | | | | | Adjustment arising during the period | (209) | | | 347 | | Income tax benefit (expense) | 44 | | | (73) | | Balance as of end-of-period | $ | 422 | | | $ | 1,021 | | Foreign Currency Translation Adjustment | | | | Balance as of beginning-of-year | $ | (26) | | | $ | (34) | | Foreign currency translation adjustment arising during the period | 8 | | | 1 | | | | | | Balance as of end-of-period | $ | (18) | | | $ | (33) | | Funded Status of Employee Benefit Plans | | | | Balance as of beginning-of-year | $ | (294) | | | $ | (278) | | | | | | Adjustment arising during the period | (8) | | | (26) | | | | | | Balance as of end-of-period | $ | (302) | | | $ | (304) | |
|
Schedule of Reclassifications Out of AOCI |
The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):
| | | | | | | | | | | | | | | | For the Nine Months Ended September 30, | | | 2024 | | 2023 | | Unrealized Gain (Loss) on Fixed Maturity AFS | | | | | Securities and Certain Other Investments | | | | | Reclassification | $ | (193) | | | $ | (1,175) | | Realized gain (loss) | Associated change in future contract benefits | 30 | | | 30 | | Benefits | Reclassification before income tax benefit (expense) | (163) | | | (1,145) | | Income (loss) before taxes | Income tax benefit (expense) | 34 | | | 247 | | Federal income tax expense (benefit) | Reclassification, net of income tax | $ | (129) | | | $ | (898) | | Net income (loss) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealized Gain (Loss) on Derivative Instruments | | | | | | | | | | Interest rate contracts | (2) | | | – | | Net investment income | | | | | | Interest rate contracts | 20 | | | 22 | | Interest and debt expense | Foreign currency contracts | 41 | | | 42 | | Net investment income | Foreign currency contracts | 1 | | | 4 | | Realized gain (loss) | | | | | | Reclassifications before income tax benefit (expense) | 60 | | | 68 | | Income (loss) before taxes | Income tax benefit (expense) | (13) | | | (14) | | Federal income tax expense (benefit) | Reclassifications, net of income tax | $ | 47 | | | $ | 54 | | Net income (loss) |
|